Basic Information
Basic information for MIR646HG-229-19aa
Peptide Name MIR646HG-229-19aa
Genome Position chr20:60125969-60126025[+]
Species Human
Peptide Sequence MGWGCCLEIRKLEKPAGTC
Peptide Length 19
Unique No (MIR646HG-213-19aa,MIR646HG-215-19aa,MIR646HG-217-19aa,MIR646HG-222-19aa,MIR646HG-234-19aa,MIR646HG-246-19aa,MIR646HG-253-19aa,MIR646HG-254-19aa)
Grand Average of Hydropathicity -0.0211
Relative Molecular Mass 2419.85
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000656658;MIR646HG-229
Transcript Length 1502
Coding Ability 0.3123
DNA Sequence Corresponding to Peptide ATGGGATGGGGGTGCTGCCTGGAAATCAGGAAACTGGAGAAGCCTGCTGGAACCTGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :